Realizing the need to improve specificity and sensitivity to detect MM, several groups have leveraged the high expression of CD38 on MM cells[13, 14, 15, 16, 17, 18, 19, 20, 21, 22] to develop molecularly targeted imaging agents. Here, CD38 is linked to Miyoshi myopathy.